Product Program year 2021 Source: CMS Open Payments

Proclaim IPG

Device Neuromodulation

PDI 05415067020239

Open in the dashboard

General payments

$2,292,598

56,604 payments

Research payments

$556,193

263 payments

Through program year 2021, $2,292,598 in general payments and $556,193 in research payments were reported against Proclaim IPG (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $2,292,598 56,604
2021 Research $556,193 263

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $2,292,598 56,604 payments
Top recipients General payments · program year 2021
  1. Sohrab Gollogly Orthopaedic Surgery of the Spine · Monterey, CA $121,469 5% · 8 payments
  2. Timothy Deer Interventional Pain Medicine · Charleston, WV $55,993 2% · 189 payments
  3. Pankaj Mehta Interventional Pain Medicine · Killeen, TX $45,425 2% · 231 payments
  4. Steven Falowski Neurological Surgery · Fountain Hill, PA $41,661 2% · 151 payments
  5. Jeffery Rowe Physical Medicine & Rehabilitation · King Of Prussia, PA $33,720 1% · 132 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Pain Medicine Pain Medicine $480,777 21% · 802 practitioners
  2. Pain Medicine Anesthesiology $399,017 17% · 1,014 practitioners
  3. Neurological Surgery $172,745 8% · 453 practitioners
  4. Orthopaedic Surgery of the Spine Orthopaedic Surgery $156,960 7% · 151 practitioners
  5. Pain Medicine $137,455 6% · 256 practitioners

The top 5 of 155 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $345,919 15% · 1,104 recipients
  2. California $310,447 14% · 674 recipients
  3. Pennsylvania $188,702 8% · 411 recipients
  4. Arizona $167,770 7% · 806 recipients
  5. Florida $151,687 7% · 668 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

56,604 general · 263 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record